PCYOX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.842400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.685200E-01
Normal-vs-Stage2
9.465400E-01
Normal-vs-Stage3
4.194800E-01
Normal-vs-Stage4
3.974800E-01
Stage1-vs-Stage2
8.749800E-01
Stage1-vs-Stage3
5.659600E-02
Stage1-vs-Stage4
2.044800E-01
Stage2-vs-Stage3
3.83619999999585E-06
Stage2-vs-Stage4
6.735700E-02
Stage3-vs-Stage4
9.104100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.968000E-01
Normal-vs-AfricanAmerican
6.216400E-01
Normal-vs-Asian
7.175000E-01
Caucasian-vs-AfricanAmerican
4.204200E-01
Caucasian-vs-Asian
4.872800E-01
AfricanAmerican-vs-Asian
2.083000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.175600E-01
Normal-vs-Female
8.744600E-01
Male-vs-Female
3.010600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.097600E-01
Normal-vs-Age(41-60Yrs)
5.266800E-01
Normal-vs-Age(61-80Yrs)
8.864600E-01
Normal-vs-Age(81-100Yrs)
3.888600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.237200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.619600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.915800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.095800E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.077300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.612800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.418600E-01
Normal-vs-Daily Drinker
5.657400E-01
Normal-vs-Weekly Drinker
8.701200E-01
Normal-vs-Occasional Drinker
5.504600E-01
Normal-vs-Social Drinker
7.231000E-01
Non Drinker-vs-Daily Drinker
9.903400E-01
Non Drinker-vs-Weekly Drinker
5.328000E-01
Non Drinker-vs-Occasional Drinker
2.450100E-02
Non Drinker-vs-Social Drinker
1.162020E-01
Daily Drinker-vs-Weekly Drinker
5.734400E-01
Daily Drinker-vs-Occasional Drinker
2.260000E-02
Daily Drinker-vs-Social Drinker
9.272300E-02
Weekly Drinker-vs-Occasional Drinker
1.787610E-01
Weekly Drinker-vs-Social Drinker
3.707800E-01
Occasional Drinker-vs-Social Drinker
7.070400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.084440E-01
Normal-vs-Grade 2
3.900400E-02
Normal-vs-Grade 3
2.734000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.310600E-01
Grade 1-vs-Grade 3
7.747800E-01
Grade 1-vs-Grade 4
1.084440E-01
Grade 2-vs-Grade 3
7.674400E-01
Grade 2-vs-Grade 4
3.900400E-02
Grade 3-vs-Grade 4
2.734000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.858200E-01
Normal-vs-NonDiabetic
9.487600E-01
Diabetic-vs-NonDiabetic
7.402600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.396000E-01
Normal-vs-NoPancreatitis
9.454400E-01
Pancreatitis-vs-NoPancreatitis
6.112400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.162800E-01
Normal-vs-N1
9.943400E-01
N0-vs-N1
6.567800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.420800E-01
Normal-vs-TP53-NonMutant
7.770000E-01
TP53-Mutant-vs-TP53-NonMutant
6.693800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
